10Jul
Proactive Due Diligence Considerations for Life Sciences Dealmakers
In today’s competitive and fast-paced life sciences dealmaking environment, buyers and investors are often unable to spend as much time on due diligence as they might like. Market players are often highly focused on the science itself and, as a...
By:
McDermott Will & Emery
Related
Economic turmoil as a result of political instability and from the coronavirus (COVID-19) pandemic, ...
Read More >
Under current Ohio law, requiring an employee to submit a urine sample for drug testing does not vio...
Read More >
The Internal Revenue Service has recently issued final regulations easing requirements for hardship ...
Read More >
I have been thinking of launching a leadership mastermind for construction professionals. And this ...
Read More >
On July 19, 2019, the U.S. District Court for the District of Rhode Island granted an employer’s mo...
Read More >
Today, data is a valuable asset for all organisations, not just ‘tech’ companies. Regardless of se...
Read More >